Health
Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform – Stockhead
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients….
Link copied toclipboard
Tragedy struck the CAR-T space this month with a US company halting a trial of its lead therapy after the deaths of two patients, a sobering reminder of the dangers involved in cell therapy.
The patients reportedly died from immune…
Continue Reading
-
Business24 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General22 hours agoFederal government funding extends cohealth GP services until July 2026
-
General6 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General9 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique